Literature DB >> 21129961

Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy.

Micheal Nottingham1, Christopher R Bethel, Sundar Ram Reddy Pagadala, Emily Harry, Abishai Pinto, Zachary A Lemons, Sarah M Drawz, Focco van den Akker, Paul R Carey, Robert A Bonomo, John D Buynak.   

Abstract

In order to evaluate the importance of a hydrogen-bond donating substituent in the design of β-lactamase inhibitors, a series of C6-substituted penicillin sulfones, lacking a C2' substituent, and having an sp(3) hybridized C6, was prepared and evaluated against a representative classes A and C β-lactamases. It was found that a C6 hydrogen-bond donor is necessary for good inhibitory activity, but that this feature alone is not sufficient in this series of C6β-substituted penicillin sulfones. Other factors which may impact the potency of the inhibitor include the steric bulk of the C6 substituent (e.g., methicillin sulfone) which may hinder recognition in the class A β-lactamases, and also high similarity to the natural substrates (e.g., penicillin G sulfone) which may render the prospective inhibitor a good substrate of both classes of enzyme. The best inhibitors had non-directional hydrogen-bonding substituents, such as hydroxymethyl, which may allow sufficient conformational flexibility of the acyl-enzyme for abstraction of the C6 proton by E166 (class A), thus promoting isomerization to the β-aminoacrylate as a stabilized acyl-enzyme.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129961      PMCID: PMC3167381          DOI: 10.1016/j.bmcl.2010.10.134

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  27 in total

1.  Structural aspects for evolution of beta-lactamases from penicillin-binding proteins.

Authors:  Samy O Meroueh; George Minasov; Wenlin Lee; Brian K Shoichet; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2003-08-13       Impact factor: 15.419

Review 2.  Clinical significance of extended-spectrum beta-lactamases.

Authors:  Jesús Rodríguez-Baño; Alvaro Pascual
Journal:  Expert Rev Anti Infect Ther       Date:  2008-10       Impact factor: 5.091

Review 3.  6-(hydroxyalkyl)penicillanates as probes for mechanisms of beta-lactamases.

Authors:  D Golemi; L Maveyraud; A Ishiwata; S Tranier; K Miyashita; T Nagase; I Massova; L Mourey; J P Samama; S Mobashery
Journal:  J Antibiot (Tokyo)       Date:  2000-10       Impact factor: 2.649

4.  The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance.

Authors:  E Gordon; N Mouz; E Duée; O Dideberg
Journal:  J Mol Biol       Date:  2000-06-02       Impact factor: 5.469

5.  Regiospecific syntheses of 6alpha-(1R-Hydroxyoctyl)penicillanic acid and 6beta-(1R-hydroxyoctyl)penicillanic acid as mechanistic probes of class D beta-lactamases.

Authors:  Sebastian A Testero; Peter I O'Daniel; Qicun Shi; Mijoon Lee; Dusan Hesek; Akihiro Ishiwata; Bruce C Noll; Shahriar Mobashery
Journal:  Org Lett       Date:  2009-06-18       Impact factor: 6.005

6.  Role of E166 in the imine to enamine tautomerization of the clinical beta-lactamase inhibitor sulbactam.

Authors:  Matthew Kalp; John D Buynak; Paul R Carey
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

Review 7.  Beta-lactamase inhibitors: the story so far.

Authors:  Francisco J Pérez-Llarena; Germán Bou
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.

Authors:  José-Manuel Rodríguez-Martínez; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

Review 9.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

10.  Penicillin-derived inhibitors that simultaneously target both metallo- and serine-beta-lactamases.

Authors:  John D Buynak; Hansong Chen; Lakshminaryana Vogeti; Venkat Rao Gadhachanda; Christine A Buchanan; Timothy Palzkill; Robert W Shaw; James Spencer; Timothy R Walsh
Journal:  Bioorg Med Chem Lett       Date:  2004-03-08       Impact factor: 2.823

View more
  1 in total

1.  Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Thomas D Gootz; Wenchi Shang; Justin Stroh; William Lau; Dale McLeod; Loren Price; Anthony Marfat; Anne Distler; Sarah M Drawz; Hansong Chen; Emily Harry; Micheal Nottingham; Paul R Carey; John D Buynak; Robert A Bonomo
Journal:  Biochem Pharmacol       Date:  2011-12-02       Impact factor: 5.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.